description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGGGACCAAAGGACAAAGAGGGGAAGCTGAGGGTGCACACCCGAGCCGTGACAGAGGATGATGAGGATGAGGATGATGACAAAGAGGATGAGGTCGGGTACATATGGTAGTGCCCACAAGAAAGAGGACACAAGTTTTGCACAAAATTGCAAGTCACTTCCTATTCCTGCATTTGTATCTAAGACTCCAAGGCACCAAGGTCTCTTCTCCATTGTTGCTCTCTATACCCGACCTAAGGTTTGGAAGACAACTGCTTGTTCCCAGAGGATTCTGATTTTGCATATGTTTGTATGGGAGAAAGGGTGTTGTGTTTTTTTTTTGTTGTTGTTTATTTTTTGGATAGGGAAGTCATTGGCTTAATTAGAGCCTCCTTCCTTTCTGTGAGATTTTTCCAACAAGCATGTGATTTACGTGGAATTCTGACAGTGCAGGGAGCCCCAACCCTCTTAAATGTCAAAGACCCTTTTTGATTACCCACACTGGTGGTTATTACAGCATGGTTCCCAGC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Yujuan Gao et al.
Journal of cellular biochemistry, 120(8), 12566-12573 (2019-03-03)
Explanation of the mechanism of resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the development of a novel strategy for drug resistance are imperative in third-generation EGFR-TKIs-resistant non-small cell lung cancer (NSCLC). SPOCK1 was found to
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持